stefan lammel gesellschaftsrecht p.jpgmorton douglas markenrecht 3.jpg

FGvW Advises Owner of Pharmaceutical Wholesaler CRANACH PHARMA on Takeover by Medios AG

Medios AG, a specialty pharma company listed on the SDAX, has acquired the Hamburg-based pharmaceutical wholesaler CRANACH PHARMA GmbH. The sole shareholder of CRANACH PHARMA GmbH was comprehensively advised on the transaction by a team of our law firm led by Stefan Lammel (M&A) and Morton Douglas (pharmaceutical law).

The transaction, with a total volume of approximately 120 million Euros, will take place by way of an exchange of shares through the acquisition of approximately 4.2 million new shares by the shareholder of CRANACH PHARMA in the context of a non-cash capital increase of Medios AG in exchange for a contribution of CRANACH PHARMA GmbH. The transaction is still subject to the approval of the German Federal Cartel Office. It is expected that the transaction can be completed in the 1st quarter of 2021.

CRANACH PHARMA GmbH is a pharmaceutical wholesaler focused primarily on pharmaceuticals in the fields of neurology, hemophilia, endocrinology, as well as ophthalmology, rheumatology and oncology. The company generated sales of more than 500 million Euros in fiscal 2019. CRANACH PHARMA has more than 20 years of established supplier relationships with the leading pharmaceutical companies in Germany as well as with pharmacies specializing in this field.

Medios AG is a leading specialty pharmaceutical company in Germany which, as a GMP-certified provider of patient-specific therapies and innovative analytical methods, primarily manufactures and distributes drugs for chronic and rare diseases.

The contact to the shareholder of CRANACH PHARMA was established through pharmaceutical lawyer Morton Douglas, who has already advised CRANACH PHARMA and its shareholder in the past.

Advisor to the sole shareholder of CRANACH PHARMA:

Stefan Lammel, Partner (Lead Partner, Corporate, M&A)
Morton Douglas, Partner (Lead, Pharmaceutical Law)
Hendrik Thies, Partner (Capital Markets Law)
Stephanie von Riegen, Associate (M&A, Merger Control)
Tina Bieniek, Associate (Corporate, M&A)
Constantin Cadmus (M&A)
Hanns-Georg Schell, Partner BANSBACH, Wirtschaftsprüfungsgesellschaft, Steuerberatungsgesellschaft, Freiburg (Lead Partner Tax Law)


Stefan Lammel
Morton Douglas


1:1. This is how we work together. You decide upon a competent partner; he/she will then remain your point of contact. > more